🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are in a “golden-era”of GDMT for pts w/ HFrEF, what barriers do we face in 25’ in implementation? Should strategies be dynamic by race/age/SE background? Our editorial in Journal of Cardiac Failure by University of Chicago Cardiology Fellowship Mary Acosta Manreet Kanwar explores this❓ 📎 onlinejcf.com/article/S1071-…

New tech alert! A wearable sensor (CardioTag) + advanced ML model estimates Pulmonary Capillary Wedge Pressure, key for heart failure, non-invasively. Tested against invasive measures, it showed strong correlation, opening doors for remote HF management sciencedirect.com/science/articl…

What is the burden of VAD related AE’s in pts w/ HM3 VAD w/ and w/out temp RVAD? At 1-Yr: ⬆️ mortality ⬆️ risk of dialysis ⬆️ stroke (propensity matched) 🟰 risk GIB, infection, VT Our large Advocate experience now in ESC Heart Failure Journal 📎 onlinelibrary.wiley.com/doi/10.1002/eh…

✅#AHFT fellowship Grateful for this yr, made lifelong friends and mentors. Cath lab exp was also incredible (for prospective applicants, hit me up to learn more!) By numbers: 282 RHC 103 biopsies 14 CardioMEMS 9 congenital 10 exercise ~60 OHT, ~50 LVADS UChicagoCardio

We're excited to see how this issue is shaping up! Only a few more days to submit your hemodynamic science! Mak Lab Dan Burkhoff MD PhD

As we go into the next cycle of fellowship application grateful for the support from AST leadership to get this team together. This is a great summary of our deep dive on how we can get more excitement around the field of solid organ transplantation. sciencedirect.com/science/articl…

Metabolic flexibility and reverse remodelling of the failing human heart CRT acutely alters the metabolic phenotype of non-ischaemic cardiomyopathy towards a more physiological picture of FA uptake which correlates with reverse remodelling. Retained metabolic flexibility may

Ever wondered what determines the hemodynamic impact of tricuspid regurgitation? What is the impact of RegVol/RegFr on RA V waves and on stroke volume? What the impact of RA compliance on RA V waves? Can we safely use indirect Fick in tricuspid regurgitation? Circ: Heart Failure 🧵👇

Very well done study! Adds a lot to understanding of TR through multi modalities. Read this thread, and, more importantly, the paper is very informative. Congrats Sergio Caravita, Claudia Baratto, & team!

Circulation Research Compendium on #Cardiopulmonary Disease and #Exercise Isabela Landsteiner et al Research Letter "Implications of #HFpEF Definitions Unveiled by Rest and Exercise #Hemodynamics" ahajrnls.org/44NfS0l @GLewisCariol Rajeev Malhotra Laura Cohen Joseph Campain

New paper in JACC Journals #JACCHF by Stratton Tolmie William F Parker, MD, PhD The University of Chicago on the net survival benefit of the 2018 Heart Tx Allocation System One definitive success: improved allocation to higher acuity pts vs. prior system More work to be done! 📎 jacc.org/doi/10.1016/j.…

Last day, Cardiology fellows & Cardiology-bound residents! Please submit your #CardiogenicShock cases for #SCAISHOCK 2025! University of Chicago Cardiology Fellowship UChicagoHVC UChicagoCardio Dhruvil A. Patel, MD Priya Nair #CardioTwitter SCAI

Just published in European Heart Journal — a global milestone in AI-powered cardiac care. UChicago Medicine’s Drs. Jeremy Slivnick and Roberto Lang (in memoriam) helped lead a multi-center, international study — in collaboration with Dr. Patricia Pellikka (Mayo Clinic) and the

Gp 1 PH with high HFpEF probability have less clinical improvement with traditional PH therapy, compared to gp 1 PH + low HFpEF prob. Do we need more intensive PH therapy, sotatercept or HFpEF therapies for these pts? Many unknowns that need RCTs. publications.ersnet.org/content/erj/ea…

🚨New analysis of ICM vs NICM in HF-CS using CCC-TN registry. ICM associated with: ⬆️comorbidities, pre-admission cardiac arrests ⬆️ RRT, ventilation ⬇️ transplant, similar LVAD rates ⬆️ Mortality 💡Etiology matters—even with similar MCS & inotropes 🔗 bit.ly/4enuQgU

🚨 Finerenone Approved by US FDA in HF based on #FINEARTSHF Finerenone (Kerendia) is a non-steroidal MRA indicated to reduce the risk of CV death, hospitalization for HF, & urgent HF visits in adult patients with HF with LVEF>= 40% bayer.com/media/en-us/us…

Happy to share CSWG's deep dive into IABP use in CS noting differential outcomes with IABP by etiology (MI vs HF) and suggesting acute hemodynamic effects of IABP may differ between these as well Rachna Kataria, MD Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Jaime Hernandez-Montfort Manreet Kanwar sciencedirect.com/science/articl…